Waycross Partners LLC Buys 658 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Waycross Partners LLC increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 2.4% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 27,794 shares of the healthcare conglomerate's stock after acquiring an additional 658 shares during the period. UnitedHealth Group comprises about 1.8% of Waycross Partners LLC's portfolio, making the stock its 26th biggest position. Waycross Partners LLC's holdings in UnitedHealth Group were worth $14,060,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. M&T Bank Corp lifted its holdings in UnitedHealth Group by 13.4% during the 3rd quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate's stock worth $128,975,000 after buying an additional 26,074 shares during the period. Sugarloaf Wealth Management LLC lifted its stake in shares of UnitedHealth Group by 17.6% in the 4th quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate's stock valued at $4,025,000 after purchasing an additional 1,193 shares during the period. Benjamin Edwards Inc. lifted its stake in shares of UnitedHealth Group by 1,275.3% in the 3rd quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate's stock valued at $26,060,000 after purchasing an additional 41,308 shares during the period. Parsifal Capital Management LP acquired a new position in shares of UnitedHealth Group in the 3rd quarter valued at about $21,165,000. Finally, Signal Advisors Wealth LLC lifted its stake in shares of UnitedHealth Group by 13.0% in the 4th quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate's stock valued at $4,611,000 after purchasing an additional 1,051 shares during the period. Institutional investors own 87.86% of the company's stock.

Insiders Place Their Bets

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the stock in a transaction dated Friday, January 17th. The stock was bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 0.33% of the company's stock.

UnitedHealth Group Stock Performance

Shares of NYSE UNH traded down $36.84 during mid-day trading on Friday, hitting $465.58. The company had a trading volume of 19,847,353 shares, compared to its average volume of 4,805,500. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock's 50-day moving average price is $519.27 and its 200-day moving average price is $560.54. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a market capitalization of $428.46 billion, a price-to-earnings ratio of 30.04, a P/E/G ratio of 1.40 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same quarter in the previous year, the company posted $5.83 earnings per share. The company's revenue was up 6.8% compared to the same quarter last year. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the company. Barclays dropped their price target on UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating on the stock in a research note on Friday, January 17th. Hsbc Global Res raised UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research note on Friday, January 10th. StockNews.com raised UnitedHealth Group from a "hold" rating to a "buy" rating in a research note on Thursday, January 23rd. HSBC raised UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 price objective for the company in a report on Friday, January 10th. Finally, Deutsche Bank Aktiengesellschaft boosted their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the stock a "buy" rating in a report on Tuesday, December 3rd. One research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat.com, UnitedHealth Group has an average rating of "Buy" and an average price target of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.